Compass Therapeutics, Inc.
CMPX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001738021
In the last 90 days, Compass Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $363.4M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Compass Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +5 vs. Q2 2022
- Shares held
- 67.4M
- +5.50M (+8.9%) vs. Q2 2022
- Total value
- $153.7M
- −$10.2M (−6.2%) vs. Q2 2022
- New holders
- 9
- 11 more added
- Sold out
- 4
- 3 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CMPX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 215 | $363.4M |
| Q1 2026 | 201 | $921.3M |
| Q4 2025 | 173 | $881.5M |
| Q3 2025 | 125 | $535.7M |
| Q2 2025 | 103 | $281.9M |
| Q1 2025 | 108 | $206.1M |
| Q4 2024 | 92 | $147.0M |
| Q3 2024 | 79 | $169.7M |
| Q2 2024 | 82 | $93.5M |
| Q1 2024 | 78 | $187.9M |
| Q4 2023 | 77 | $134.8M |
| Q3 2023 | 76 | $176.7M |
| Q2 2023 | 73 | $287.7M |
| Q1 2023 | 73 | $285.1M |
| Q4 2022 | 55 | $401.4M |
| Q3 2022 | 38 | $153.7M |
| Q2 2022 | 34 | $163.9M |
| Q1 2022 | 34 | $85.4M |
| Q4 2021 | 37 | $201.6M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Compass Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 21,960,850 | $50.1M | 0.93% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 7,045,960 | $16.1M | 0.01% | +3,698,789+110.5% | Added |
| FMR LLC | 6,354,814 | $14.5M | 0.00% | −517,600−7.5% | Reduced |
| Rock Springs Capital Management LP | 5,333,188 | $12.2M | 0.31% | +5,100+0.1% | Added |
| Adage Capital Partners GP, L.L.C. | 4,606,600 | $10.5M | 0.03% | +200,000+4.5% | Added |
| Foresite Capital Management V, LLC | 4,400,000 | $10.0M | 7.71% | 00.0% | Unchanged |
| CHI Advisors LLC | 2,829,712 | $6.45M | 1.73% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,380,623 | $5.43M | 0.00% | +878,650+58.5% | Added |
| Vivo Capital, LLC | 2,000,000 | $4.56M | 0.50% | 00.0% | Unchanged |
| Avidity Partners Management LP | 2,000,000 | $4.56M | 0.10% | 00.0% | Unchanged |
| Foresite Capital Opportunity Management V, LLC | 1,554,250 | $3.54M | 10.64% | 00.0% | Unchanged |
| Blackstone Group Inc. | 1,505,738 | $3.43M | 0.01% | 00.0% | Unchanged |
| Monashee Investment Management LLC | 1,230,441 | $2.81M | 1.04% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 1,100,399 | $2.51M | 0.05% | +1,100,399 | New |
| BlackRock Inc. | 872,497 | $1.99M | 0.00% | +709,071+433.9% | Added |
| Fred Alger Management, LLC | 608,536 | $1.39M | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 601,324 | $1.37M | 0.00% | +576,467+2,319.1% | Added |
| Silverarc Capital Management, LLC | 262,090 | $598.0K | 0.25% | +262,090 | New |
| DAFNA Capital Management LLC | 188,094 | $429.0K | 0.12% | −10,000−5.0% | Reduced |
| LMR Partners LLP | 100,000 | $228.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 87,367 | $199.0K | 0.00% | +87,367 | New |
| Renaissance Technologies LLC | 64,215 | $146.0K | 0.00% | −1,950−2.9% | Reduced |
| Millennium Management LLC | 63,187 | $144.0K | 0.00% | +35,326+126.8% | Added |
| Marshall Wace, LLP | 51,816 | $117.0K | 0.00% | +28,089+118.4% | Added |
| Charles Schwab Investment Management Inc | 31,736 | $73.0K | 0.00% | +31,736 | New |
| Salem Investment Counselors Inc | 30,000 | $68.0K | 0.00% | 00.0% | Unchanged |
| New Capital Management LP | 24,243 | $55.0K | 0.03% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 24,251 | $55.0K | 0.00% | +24,251 | New |
| Susquehanna International Group, LLP | 19,738 | $45.0K | 0.00% | +19,738 | New |
| Jane Street Group, LLC | 14,265 | $33.0K | 0.00% | +14,265 | New |
| Flagship Harbor Advisors, LLC | 14,000 | $32.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 8,872 | $20.0K | 0.00% | +8,259+1,347.3% | Added |
| UBS Group AG | 7,228 | $16.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 4,533 | $10.0K | 0.00% | +3,163+230.9% | Added |
| Royal Bank of Canada | 675 | $2.00K | 0.00% | +447+196.1% | Added |
| Wells Fargo & Company | 457 | $1.00K | 0.00% | +457 | New |
| Barclays PLC | 374 | $1.00K | 0.00% | +374 | New |
| Advisor Group Holdings, Inc. | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Consonance Capital Management LP | 0 | $0 | 0.00% | −1,603,789−100.0% | Sold out |
| CM Management, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Mascoma Wealth Management LLC | 0 | $0 | 0.00% | −15,682−100.0% | Sold out |
| Charter Oak Capital Management, LLC | 0 | $0 | 0.00% | −1,483−100.0% | Sold out |
| B. Riley Wealth Management, Inc. | – | – | – | – | Not filed |